US Patent Issued to The University of North Carolina at Chapel Hill on May 20 for "Methods and compositions for modified factor IX fusion proteins" (North Carolina Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,944, issued on May 20, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.).

"Methods and compositions for modified factor IX fusion proteins" was invented by Tal Kafri (Carrboro, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides Factor IX fusion proteins with higher specific activity and a longer useful clotting function relative to wild type or non-modified Factor IX protein."

The patent was filed on Dec. 19, 2022, under Application No. 18/068,376.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...